| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/12/2004 | WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2003004677A9 Methods for generating differential profiles by combining data obtained in separate measurements |
| 02/12/2004 | WO2003001183A3 Methods for detecting and monitoring cox-2 rna in plasma and serum |
| 02/12/2004 | WO2003000897A8 Identification and characterization of phosphate transporter genes |
| 02/12/2004 | WO2002101357A9 Molecular signatures of commonly fatal carcinomas |
| 02/12/2004 | WO2002096198A3 Methods for the identification of inhibitors of 3-oxo-5-alpha-steroid 4-dehydrogenase expression or activity in plants |
| 02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
| 02/12/2004 | WO2002079411A3 Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification |
| 02/12/2004 | WO2002077895A3 Method for epigenetic feature selection |
| 02/12/2004 | WO2002077640A8 Systems for analysis of biological materials |
| 02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002064824A3 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization |
| 02/12/2004 | WO2002064821A3 Method for analysing macromolecules |
| 02/12/2004 | WO2002064747A3 Fusion proteins based upon somatostatin receptors |
| 02/12/2004 | WO2002062952A3 Non-cytotoxic pap mutants |
| 02/12/2004 | WO2002061045A3 Simplified method for indexing and determining the relative concentration of expressed messenger rnas |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
| 02/12/2004 | WO2002052047A3 Methods for identifying g-protein coupled receptors associated with diseases |
| 02/12/2004 | WO2002052046A3 Oligonucleotide transfection screening method |
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | US20040031073 Method for modifying plant morphology, biochemistry and physiology |
| 02/12/2004 | US20040031065 Neuronal activation in a transgenic model |
| 02/12/2004 | US20040030503 Neural -network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including susceptibility to disease |
| 02/12/2004 | US20040030473 System for dynamically determining the wheel grounding and wheel lifting conditions and their applications in roll stability control |
| 02/12/2004 | US20040030404 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 02/12/2004 | US20040030159 Surface coating agents |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040029823 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029802 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029554 Method for histocompatibility testing |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029275 Short interfering RNA (siRNAs); reducing expression by obtaining and introducing into a cell multiple single or double stranded RNAs (dsRNAs) or DNA constructs capable of expressing multiple siRNAs in cells |
| 02/12/2004 | US20040029260 A fully automated and integrated system that comprises a pipetter, extractor and an assay reader |
| 02/12/2004 | US20040029258 Methods and devices for performing chemical reactions on a solid support |
| 02/12/2004 | US20040029255 The use of primers to detect specific isolates of fungal pathogens and the monitoring of disease development in plants; Colletotrichum acutatum, Alternaria spp., and Cladosporium carpophilum |
| 02/12/2004 | US20040029254 Method of screening anti-bacterial agents for effectiveness in treating persistant intracellular infections |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029241 Formulation and use of a polymerization process employing biocompatible polymers and biocompatible polymerization conditions, such as neutral pH, where there is maintenance of an aqueous environment |
| 02/12/2004 | US20040029235 Comprises exposing the pin head or other implement to ultraviolet (UV) and preferably also infrared (IR) radiation between handling different samples in order to suppress cross-contamination by non-specific amplification |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029223 Two bacterial strains deficient in endogenous adenylate cyclase activity are used in a signal amplification system comprising a bacterial multi-hybrid system |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029212 By differentiation of said microorganisms by the appearance of different colors in the colonies, which may be regular or irregular, and halos different colors and sizes |
| 02/12/2004 | US20040029211 By applying a solution or dispersion of a fluorogenic reagent in water to the hidden water contact surfaces of industrial water system and allowing said fluorogenic reagent to react with any hidden microorganisms |
| 02/12/2004 | US20040029207 Cycclooxygenase-2 (COX-2); detecting and measuring COX-2 specific ammino acid eicosanoid metabolites, prostaglandinH2-glycine and/or hydroxy eicosatetranoic-glycine; COX-2 selective substrates |
| 02/12/2004 | US20040029206 Phosphatidylinositol bisphosphate (PIP2) indicatorof membrane molecules using fluorescence resonance energy transfer (FRET) |
| 02/12/2004 | US20040029205 By a test strip or stick assay, or other similar assays, for detecting the presence of leukocyte esterase which correlates to the presence of sputum; analysis to determine the presence of respiratory pathogens associated with pulmonary diseases |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029201 Identification of targets of antimicrobial compounds |
| 02/12/2004 | US20040029200 Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029193 Comprises monodisperse polymer particles of human albumin, fibrin, fibrinogen or polyphenylmethacrylate for quantitative measuring of the adhesion of platelets in vitro |
| 02/12/2004 | US20040029192 By detecting polymorphisms associated with CD2AP protein; gel electrophoresis; fluorescence resonance energy transfer |
| 02/12/2004 | US20040029191 Detection of kinase substrates and products using ion mass spectrometry |
| 02/12/2004 | US20040029190 Automated methods of detecting receptor activity |
| 02/12/2004 | US20040029187 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/12/2004 | US20040029186 Methods |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029176 By measuring metalloproteinase-8 (MMP-8) concentration in amniotic fluid; uterine infections; kits |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029173 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 02/12/2004 | US20040029172 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 02/12/2004 | US20040029165 Automatic sequencing kits |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029161 Methods for genomic analysis |
| 02/12/2004 | US20040029160 A triplex comprising a hairpin having polypyrimidine sequence linked to a complementary polypurine; targeting single-stranded oligonucleotides and DNA using the hairpins and triplexes |
| 02/12/2004 | US20040029159 Cell lineage determination and genetic switches and mobile element related genes and their role in genetic programming during development or cell lineage decisions |
| 02/12/2004 | US20040029158 HOP - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 02/12/2004 | US20040029156 Immobilization of biomolecules on substrates by attaching them to adsorbed bridging biomolecules |
| 02/12/2004 | US20040029155 Method for identifying a biomolecule |
| 02/12/2004 | US20040029153 Method for estimating metabolic function of xenobiotic and induction thereof |
| 02/12/2004 | US20040029152 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
| 02/12/2004 | US20040029151 Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029149 Human metabolic models and methods |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029146 Diagnosis and treatment of infectious diseases such as chlamydia |
| 02/12/2004 | US20040029145 Novel HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality, and feed efficiency traits |
| 02/12/2004 | US20040029144 Used in the diagnosis, treatment, and prevention of cell proliferative disorders, including cancer, and developmental, autoimmune/inflammatory and neurological disorders |
| 02/12/2004 | US20040029143 Comprising multiple quaternary ammonium residues like poly (diallyldimethylammonium)chloride (PDADMAC) polynucleotides; a strong interaction is formed that may be utilized in separation techniques |
| 02/12/2004 | US20040029142 Methods and kits for detecting the presence of a predefined nucleotide at a predefined position in a nucleic acid; used in diagnosis of disorders in a subject |
| 02/12/2004 | US20040029139 System for simultaneous detection of multiple binding events in the same reaction |
| 02/12/2004 | US20040029135 Biological and chemical warfare agents (BCWA); detecting a target analyte protecting a specific target analyte in a sample, eliminating non-specific analytes, and detecting the presence of target with a signal |
| 02/12/2004 | US20040029133 Mitochondrial DNA polymorphisms |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029130 Involving components of the non-homologous end joining (NHEJ) pathway, and to screening systems which make use of the protein kinase known as DNA-PK (DNA-dependent protein kinase) and related protein kinases |